360
Participants
Start Date
December 15, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
XY03-EA
"The sample size was 360 patients, and 72patients were treated with XY03-EA 150 mg, 300mgA group ,300mgBgroup,450mg and placebo respectively. The 150mg group took two tablets of placebo and one tablet of XY03-EA once, three times a day. For 90 days The 300mg A-group took one tablet of placebo and two tablets of XY03-EA once,three times a day. For 90 days The 300mg B-group took one tablet of placebo and two tablets of XY03-EA once,three times a day. Use continuously for 14 days.Placebo is used for 15-90 days.~The 450mg group took three tablets of XY03-EA once,three times a day. For 90 days.~The placebo group took three tablets of placebo once ,three times a day.For 90 days."
Shijiazhuang Yiling Pharmaceutical Co., Ltd, Shijiazhuang
Shijiazhuang Yiling Pharmaceutical Co. Ltd
INDUSTRY